Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Antibody drugs could help curb pandemic, Barron's says » 09:40
06/06/20
06/06
09:40
06/06/20
09:40
GSK

GlaxoSmithKline

$41.69 /

+0.04 (+0.10%)

, VIR

Vir Biotechnology

$33.16 /

-1.06 (-3.10%)

, LLY

Eli Lilly

$149.21 /

-1.44 (-0.96%)

, REGN

Regeneron

$597.27 /

-0.94 (-0.16%)

, NVAX

Novavax

$46.22 /

+1.54 (+3.45%)

, MRNA

Moderna

$58.16 /

-2.44 (-4.03%)

Chasing COVID-19 vaccine…

Chasing COVID-19 vaccine news has sent investors on a wild ride this spring, as shares of biotechs like Moderna (MRNA) and Novavax (NVAX) have spiked one day and crashed the next, Josh Nathan-Kazis writes in this week's edition of Barron's. Over the next few months, a handful of pharmaceutical companies plan to begin testing a new category of drugs designed to treat, or even prevent, a COVID-19 infection. Called monoclonal antibodies, the drugs mimic the proteins a human body would make to fight the virus that causes COVID-19, and while they don't hold out the promise of eliminating the threat of COVID-19 in the way that an effective vaccine could, the new antibodies could help curb the pandemic, he notes. This summer, at least three programs aim to begin testing their antibodies in humans, namely Eli Lilly (LLY), Regeneron Pharmaceuticals (REGN), and a collaboration between Vir Biotechnology (VIR) and GlaxoSmithKline (GSK). Reference Link

ShowHide Related Items >><<
VIR Vir Biotechnology
$33.16 /

-1.06 (-3.10%)

REGN Regeneron
$597.27 /

-0.94 (-0.16%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

LLY Eli Lilly
$149.21 /

-1.44 (-0.96%)

GSK GlaxoSmithKline
$41.69 /

+0.04 (+0.10%)

GSK GlaxoSmithKline
$41.69 /

+0.04 (+0.10%)

05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
05/05/20 JPMorgan
GlaxoSmithKline price target lowered to 1,700 GBp from 1,750 GBp at JPMorgan
04/30/20 Barclays
GlaxoSmithKline price target raised to 1,550 GBp from 1,450 GBp at Barclays
03/11/20 JPMorgan
JPMorgan backs Neutral on GSK after 2019 annual report
VIR Vir Biotechnology
$33.16 /

-1.06 (-3.10%)

05/13/20 Barclays
Vir Biotechnology price target raised to $44 from $41 at Barclays
03/19/20 JPMorgan
JPMorgan downgrades Vir Biotechnology to Underweight after 290% rally
03/19/20 JPMorgan
Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan
03/13/20 Goldman Sachs
Vir Biotechnology downgraded to Neutral from Buy at Goldman Sachs
LLY Eli Lilly
$149.21 /

-1.44 (-0.96%)

06/05/20 Piper Sandler
Nektar sees 'encouraging trends' in early lupus trial, says Piper Sandler
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
05/29/20 Raymond James
Blueprint approval for pralsetinib could come before PDUFA, says Raymond James
REGN Regeneron
$597.27 /

-0.94 (-0.16%)

06/02/20 Cantor Fitzgerald
Regeneron price target raised to $624 from $400 at Cantor Fitzgerald
05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/28/20 Barclays
Regeneron price target raised to $615 from $530 at Barclays
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
NVAX Novavax
$46.22 /

+1.54 (+3.45%)

06/05/20
Fly Intel: Top five analyst upgrades
06/05/20 JPMorgan
JPMorgan upgrades Novavax to Neutral despite 'shaky fundamentals'
06/05/20 B. Riley FBR
Novavax price target raised to $74 from $61 at B. Riley FBR
06/05/20 JPMorgan
Novavax upgraded to Neutral from Underweight at JPMorgan
MRNA Moderna
$58.16 /

-2.44 (-4.03%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
VIR Vir Biotechnology
$33.16 /

-1.06 (-3.10%)

REGN Regeneron
$597.27 /

-0.94 (-0.16%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

LLY Eli Lilly
$149.21 /

-1.44 (-0.96%)

GSK GlaxoSmithKline
$41.69 /

+0.04 (+0.10%)

VIR Vir Biotechnology
$33.16 /

-1.06 (-3.10%)

REGN Regeneron
$597.27 /

-0.94 (-0.16%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

LLY Eli Lilly
$149.21 /

-1.44 (-0.96%)

GSK GlaxoSmithKline
$41.69 /

+0.04 (+0.10%)

VIR Vir Biotechnology
$33.16 /

-1.06 (-3.10%)

REGN Regeneron
$597.27 /

-0.94 (-0.16%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

LLY Eli Lilly
$149.21 /

-1.44 (-0.96%)

GSK GlaxoSmithKline
$41.69 /

+0.04 (+0.10%)

VIR Vir Biotechnology
$33.16 /

-1.06 (-3.10%)

REGN Regeneron
$597.27 /

-0.94 (-0.16%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

GSK GlaxoSmithKline
$41.69 /

+0.04 (+0.10%)

On The Fly
Week in Review: How Trump's policies moved stocks » 07:19
06/06/20
06/06
07:19
06/06/20
07:19
AZN

AstraZeneca

$53.87 /

+ (+0.00%)

, JNJ

Johnson & Johnson

$147.27 /

+0.61 (+0.42%)

, MRK

Merck

$82.26 /

+0.71 (+0.87%)

, MRNA

Moderna

$58.16 /

-2.44 (-4.03%)

, PFE

Pfizer

$35.97 /

-0.035 (-0.10%)

, INO

Inovio

$11.96 /

+0.09 (+0.76%)

, NVAX

Novavax

$46.22 /

+1.54 (+3.45%)

, AIRYY

Air China

$0.00 /

+ (+0.00%)

, CEA

China Eastern Airlines

$20.34 /

+1.54 (+8.19%)

, ZNH

China Southern Airlines

$25.21 /

+2.57 (+11.35%)

, AAL

American Airlines

$18.59 /

+1.855 (+11.08%)

, DAL

Delta Air Lines

$34.15 /

+1.77 (+5.47%)

, UAL

United Airlines

$42.41 /

+3.33 (+8.52%)

, SNAP

Snap

$20.32 /

+1.065 (+5.53%)

, FB

Facebook

$230.64 /

+4.38 (+1.94%)

, GOOG

Alphabet

$1,436.75 /

+24.625 (+1.74%)

, GOOGL

Alphabet Class A

$1,440.74 /

+26.62 (+1.88%)

, AAPL

Apple

$331.38 /

+9.09 (+2.82%)

, AMZN

Amazon.com

$2,481.08 /

+20.67 (+0.84%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
ZNH China Southern Airlines
$25.21 /

+2.57 (+11.35%)

UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

CEA China Eastern Airlines
$20.34 /

+1.54 (+8.19%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AIRYY Air China
$0.00 /

+ (+0.00%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

06/04/20 UBS
AstraZeneca price target raised to 7,300 GBp from 6,000 GBp at UBS
06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.26 /

+0.71 (+0.87%)

06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
MRNA Moderna
$58.16 /

-2.44 (-4.03%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
PFE Pfizer
$35.97 /

-0.035 (-0.10%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
INO Inovio
$11.96 /

+0.09 (+0.76%)

06/04/20 Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
NVAX Novavax
$46.22 /

+1.54 (+3.45%)

06/05/20
Fly Intel: Top five analyst upgrades
06/05/20 JPMorgan
JPMorgan upgrades Novavax to Neutral despite 'shaky fundamentals'
06/05/20 B. Riley FBR
Novavax price target raised to $74 from $61 at B. Riley FBR
06/05/20 JPMorgan
Novavax upgraded to Neutral from Underweight at JPMorgan
AIRYY Air China
$0.00 /

+ (+0.00%)

03/18/20 Jefferies
Jefferies downgrades four China airlines on 'U-shaped' pandemic recovery
03/18/20 Jefferies
Air China downgraded to Underperform from Buy at Jefferies
03/09/20 Daiwa
Air China upgraded to Buy from Outperform at Daiwa
10/14/19 Goldman Sachs
Goldman upgrades China Southern to Buy on slower supply growth
CEA China Eastern Airlines
$20.34 /

+1.54 (+8.19%)

03/18/20 Jefferies
China Eastern Airlines downgraded to Hold from Buy at Jefferies
12/20/19 Daiwa
China Eastern Airlines upgraded to Buy from Outperform at Daiwa
ZNH China Southern Airlines
$25.21 /

+2.57 (+11.35%)

04/27/20 UBS
China Southern Airlines upgraded to Buy from Neutral at UBS
04/21/20 Credit Suisse
China Southern Airlines upgraded to Outperform from Neutral at Credit Suisse
03/18/20 Jefferies
China Southern Airlines downgraded to Hold from Buy at Jefferies
AAL American Airlines
$18.59 /

+1.855 (+11.08%)

06/05/20 Credit Suisse
American stock reaction to demand commentary 'confounding,' says Credit Suisse
06/05/20
Fly Intel: Top five analyst downgrades
06/05/20 Raymond James
American Airlines downgraded to Underperform from Market Perform at Raymond James
06/05/20 Raymond James
American downgraded to Underperform from Market Perform at Raymond James
DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
05/04/20 Barclays
Delta Air Lines downgraded to Equal Weight from Overweight at Barclays
04/23/20 Raymond James
Delta Air Lines price target lowered to $36 from $40 at Raymond James
UAL United Airlines
$42.41 /

+3.33 (+8.52%)

05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/19/20 Goldman Sachs
Southwest, United seeing modest improvements in demand, says Goldman Sachs
SNAP Snap
$20.32 /

+1.065 (+5.53%)

06/01/20 Deutsche Bank
Snap price target raised to $24 from $18 at Deutsche Bank
05/06/20
Fly Intel: Top five analyst downgrades
05/06/20 Citi
Snap downgraded to Sell from Neutral at Citi
04/27/20 JMP Securities
Facebook Q1 should benefit from same headwinds as Snap, says JMP Securities
FB Facebook
$230.64 /

+4.38 (+1.94%)

05/29/20 Baird
Twitter, Facebook pullbacks would likely be buying opportunities, says Baird
05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

06/02/20 Wells Fargo
Microsoft price target raised to $250 from $205 at Wells Fargo
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

06/05/20 Credit Suisse
Apple price target raised to $295 from $260 at Credit Suisse
06/04/20 JPMorgan
'Way too early' for investors to write off Apple TV+, says JPMorgan
06/03/20 Bernstein
Apple could offer less expensive, easier to use Watch, says Bernstein
06/03/20 Morgan Stanley
Apple price target raised to $340 from $326 at Morgan Stanley
AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

06/05/20 DA Davidson
MongoDB price target raised to $215 from $105 at DA Davidson
06/05/20 SunTrust
eBay price target raised to $50 from $40 at SunTrust
06/05/20 RBC Capital
Slack Technologies price target raised to $38 from $28 at RBC Capital
06/05/20 JMP Securities
Domo price target raised to $35 from $22 at JMP Securities
UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

ZNH China Southern Airlines
$25.21 /

+2.57 (+11.35%)

UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AIRYY Air China
$0.00 /

+ (+0.00%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

ZNH China Southern Airlines
$25.21 /

+2.57 (+11.35%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

Friday
General news
Fauci 'cautiously optimistic' at least one Phase 3 vaccine trial starts in July » 12:36
06/05/20
06/05
12:36
06/05/20
12:36
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$319.72 /

+8.42 (+2.70%)

, MRNA

Moderna

$57.29 /

-3.31 (-5.46%)

, JNJ

Johnson & Johnson

$148.84 /

+2.18 (+1.49%)

, MRK

Merck

$82.61 /

+1.06 (+1.30%)

, PFE

Pfizer

$36.11 /

+0.105 (+0.29%)

, NVAX

Novavax

$46.00 /

+1.32 (+2.95%)

, INO

Inovio

$11.43 /

-0.44 (-3.71%)

, AZN

AstraZeneca

$54.12 /

+0.25 (+0.46%)

Fauci said he is…

Fauci said he is "cautiously optimistic" that "at least one" Phase 3 trial testing a COVID_19 vaccine candidate can start in early July and that "a few others" should be able to start by early fall. If things break correctly, "we can have an answer" by the end of this calendar year or early in 2021 if there is a safe and effective vaccine that has been found, added Fauci. Companies working on potential COVID-19 vaccines include Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Merck (MRK), Pfizer (PFE), Novavax (NVAX) and Inovio (INO). Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is being interviewed on CNBC.

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.61 /

+1.06 (+1.30%)

06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
PFE Pfizer
$36.11 /

+0.105 (+0.29%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
NVAX Novavax
$46.00 /

+1.32 (+2.95%)

06/05/20
Fly Intel: Top five analyst upgrades
06/05/20 JPMorgan
JPMorgan upgrades Novavax to Neutral despite 'shaky fundamentals'
06/05/20 B. Riley FBR
Novavax price target raised to $74 from $61 at B. Riley FBR
06/05/20 JPMorgan
Novavax upgraded to Neutral from Underweight at JPMorgan
INO Inovio
$11.43 /

-0.44 (-3.71%)

06/04/20 Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

06/04/20 UBS
AstraZeneca price target raised to 7,300 GBp from 6,000 GBp at UBS
06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Thursday
On The Fly
Inovio, Novavax analysts undeterred by White House vaccine snub » 11:12
06/04/20
06/04
11:12
06/04/20
11:12
INO

Inovio

$12.52 /

+0.07 (+0.56%)

, NVAX

Novavax

$44.38 /

+0.12 (+0.27%)

, MRNA

Moderna

$59.95 /

+0.065 (+0.11%)

, AZN

AstraZeneca

$54.45 /

-0.55 (-1.00%)

, JNJ

Johnson & Johnson

$146.14 /

-2.54 (-1.71%)

, MRK

Merck

$81.26 /

-0.81 (-0.99%)

, PFE

Pfizer

$35.97 /

-0.185 (-0.51%)

Shares of Inovio…

Open Full Text

ShowHide Related Items >><<
PFE Pfizer
$35.97 /

-0.185 (-0.51%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

06/04/20 Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
NVAX Novavax
$44.38 /

+0.12 (+0.27%)

06/03/20 B. Riley FBR
Novavax selloff on 'Warp Speed' report unwarranted, says B. Riley FBR
05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
MRNA Moderna
$59.95 /

+0.065 (+0.11%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$81.26 /

-0.81 (-0.99%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
PFE Pfizer
$35.97 /

-0.185 (-0.51%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
PFE Pfizer
$35.97 /

-0.185 (-0.51%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

Hot Stocks
Moderna appoints David Meline as CFO » 08:11
06/04/20
06/04
08:11
06/04/20
08:11
MRNA

Moderna

$59.89 /

+0.005 (+0.01%)

Moderna (MRNA) announced…

Moderna (MRNA) announced that David Meline has joined Moderna as CFO, effective Monday, June 8. He will serve on Moderna's Executive Committee and report to CEO Stephane Bancel. Meline joins Moderna from Amgen (AMGN), where he served as CFO and EVP from 2014 through 2019.

ShowHide Related Items >><<
MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

Wednesday
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:34
06/03/20
06/03
16:34
06/03/20
16:34
ZM

Zoom Video

$223.91 /

+15.91 (+7.65%)

, CRWD

Crowdstrike

$98.11 /

+5.945 (+6.45%)

, WMG

Warner Music

$30.07 /

+ (+0.00%)

, PLRX

Pliant Therapeutics

$21.35 /

+ (+0.00%)

, MRNA

Moderna

$59.89 /

+0.005 (+0.01%)

, INO

Inovio

$12.43 /

-1.94 (-13.50%)

, NVAX

Novavax

$44.26 /

-5.315 (-10.72%)

, AZN

AstraZeneca

$55.00 /

+0.285 (+0.52%)

, MRK

Merck

$82.07 /

+1.22 (+1.51%)

, JNJ

Johnson & Johnson

$148.68 /

+0.52 (+0.35%)

, PFE

Pfizer

$36.15 /

-0.01 (-0.03%)

, SNAP

Snap

$19.73 /

-0.035 (-0.18%)

, CAKE

Cheesecake Factory

$24.35 /

+3.41 (+16.28%)

, CRTO

Criteo

$13.26 /

+2.08 (+18.60%)

, ROKU

Roku

$103.90 /

-6.92 (-6.24%)

, BBY

Best Buy

$82.23 /

+1.76 (+2.19%)

, PPC

Pilgrim's Pride

$18.30 /

-2.58 (-12.36%)

Stocks continue to find…

Open Full Text

ShowHide Related Items >><<
ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

WMG Warner Music
$30.07 /

+ (+0.00%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CRTO Criteo
$13.26 /

+2.08 (+18.60%)

CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

06/03/20
Fly Intel: Top five analyst upgrades
06/03/20 Needham
Zoom Video price target raised to $230 from $140 at Needham
06/03/20 FBN Securities
Zoom Video upgraded to Outperform from Sector Perform at FBN Securities
06/03/20 JPMorgan
Wowed JPMorgan raises Zoom Video price target to $220 from $150
CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

06/03/20 JPMorgan
Crowdstrike price target raised to $120 from $109 at JPMorgan
06/03/20 BTIG
Crowdstrike price target raised to $115 from $80 at BTIG
06/03/20 DA Davidson
Crowdstrike price target raised to $120 from $105 at DA Davidson
06/03/20 Oppenheimer
Crowdstrike price target raised to $110 from $85 at Oppenheimer
WMG Warner Music
$30.07 /

+ (+0.00%)

06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Atlantic Equities
Warner Music initiated with a Neutral at Atlantic Equities
PLRX Pliant Therapeutics
$21.35 /

+ (+0.00%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
INO Inovio
$12.43 /

-1.94 (-13.50%)

06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
05/20/20 Piper Sandler
Piper Sandler stays Neutral on Inovio, offers a 'little perspective' on vaccine
NVAX Novavax
$44.26 /

-5.315 (-10.72%)

06/03/20 B. Riley FBR
Novavax selloff on 'Warp Speed' report unwarranted, says B. Riley FBR
05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
MRK Merck
$82.07 /

+1.22 (+1.51%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
PFE Pfizer
$36.15 /

-0.01 (-0.03%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
SNAP Snap
$19.73 /

-0.035 (-0.18%)

06/01/20 Deutsche Bank
Snap price target raised to $24 from $18 at Deutsche Bank
05/06/20
Fly Intel: Top five analyst downgrades
05/06/20 Citi
Snap downgraded to Sell from Neutral at Citi
04/27/20 JMP Securities
Facebook Q1 should benefit from same headwinds as Snap, says JMP Securities
CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

06/03/20 Stephens
Stephens stays Underweight Cheesecake Factory after reopening update
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Stephens
Cheesecake Factory resumed Underweight from Equal Weight at Stephens
05/07/20 Loop Capital
Cheesecake Factory price target lowered to $23 from $44 at Loop Capital
CRTO Criteo
$13.26 /

+2.08 (+18.60%)

05/08/20 Deutsche Bank
Criteo price target lowered to $16 from $22 at Deutsche Bank
05/05/20 SunTrust
Criteo price target lowered to $13 from $25 at SunTrust
04/20/20 Nomura Instinet
Criteo price target lowered to $10 from $14 at Nomura Instinet
04/08/20 Societe Generale
Criteo upgraded to Buy from Hold at Societe Generale
ROKU Roku
$103.90 /

-6.92 (-6.24%)

06/03/20 Stephens
Roku may be seeing pressure from Best Buy TCL TVs, says Stephens
06/03/20 SunTrust
New TVs at Best Buy present 'modest' new competition for Roku, says Suntrust
05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Stephens
Roku downgraded to Equal Weight on worries about TCL at Stephens
BBY Best Buy
$82.23 /

+1.76 (+2.19%)

05/22/20 Loop Capital
Best Buy price target raised to $90 from $80 at Loop Capital
05/22/20 Morgan Stanley
Best Buy price target raised to $85 from $75 at Morgan Stanley
PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

06/03/20 Stephens
Stephens downgrades Pilgrim's Pride after indictment, suspends targets on peers
06/03/20 Stephens
Pilgrim's Pride downgraded to Equal Weight from Overweight at Stephens
05/11/20 Stephens
Stephens upgrades Pilgrim's Pride, says navigating current environment well
05/11/20 Stephens
Pilgrim's Pride upgraded to Overweight from Equal Weight at Stephens
ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CRTO Criteo
$13.26 /

+2.08 (+18.60%)

CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

  • 03
    Jun
  • 03
    Jun
ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

WMG Warner Music
$30.07 /

+ (+0.00%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

WMG Warner Music
$30.07 /

+ (+0.00%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CRTO Criteo
$13.26 /

+2.08 (+18.60%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

On The Fly
Moderna rises, Novavax plunges as White House names COVID finalists » 14:17
06/03/20
06/03
14:17
06/03/20
14:17
MRNA

Moderna

$60.70 /

+0.82 (+1.37%)

, INO

Inovio

$12.48 /

-1.89 (-13.15%)

, NVAX

Novavax

$42.29 /

-7.28 (-14.69%)

, AZN

AstraZeneca

$55.25 /

+0.535 (+0.98%)

, JNJ

Johnson & Johnson

$148.00 /

-0.16 (-0.11%)

, MRK

Merck

$82.13 /

+1.28 (+1.58%)

, PFE

Pfizer

$35.97 /

-0.19 (-0.53%)

Shares of Moderna (MRNA)…

Open Full Text

ShowHide Related Items >><<
PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
INO Inovio
$12.48 /

-1.89 (-13.15%)

06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
05/20/20 Piper Sandler
Piper Sandler stays Neutral on Inovio, offers a 'little perspective' on vaccine
NVAX Novavax
$42.29 /

-7.28 (-14.69%)

06/03/20 B. Riley FBR
Novavax selloff on 'Warp Speed' report unwarranted, says B. Riley FBR
05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.13 /

+1.28 (+1.58%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
PFE Pfizer
$35.97 /

-0.19 (-0.53%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

Hot Stocks
Moderna jumps 4% to $62.24 after making White House vaccine finalist list  13:21
06/03/20
06/03
13:21
06/03/20
13:21
MRNA

Moderna

$60.25 /

+0.37 (+0.62%)

 
ShowHide Related Items >><<
MRNA Moderna
$60.25 /

+0.37 (+0.62%)

MRNA Moderna
$60.25 /

+0.37 (+0.62%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
MRNA Moderna
$60.25 /

+0.37 (+0.62%)

MRNA Moderna
$60.25 /

+0.37 (+0.62%)

MRNA Moderna
$60.25 /

+0.37 (+0.62%)

MRNA Moderna
$60.25 /

+0.37 (+0.62%)

Periodicals
Novavax sinks after White House omits as COVID vaccine finalist » 13:16
06/03/20
06/03
13:16
06/03/20
13:16
MRK

Merck

$81.74 /

+0.89 (+1.10%)

, AZN

AstraZeneca

$54.71 /

-0.005 (-0.01%)

, PFE

Pfizer

$35.72 /

-0.44 (-1.22%)

, JNJ

Johnson & Johnson

$147.44 /

-0.72 (-0.49%)

, MRNA

Moderna

$59.63 /

-0.25 (-0.42%)

, NVAX

Novavax

$48.10 /

-1.47 (-2.97%)

The New York Times this…

The New York Times this afternoon reported that Moderna (MRNA) is among the five finalists selected by the Trump administration as the most likely to produce a vaccine for the coronavirus. By narrowing the field, the White House is betting it can identify the most promising vaccines at an early stage, speed along the process of determining which will work and ensure that the winner or winners can be quickly manufactured in large quanities, the Times said. A White House announcement is expected in the new few weeks. In addition to Moderna, the winners are AstraZeneca (AZN), Johnson & Johnson (JNJ), Merck (MRK) and Pfizer (PFE), according the Times. Shares of Moderna are down 11c to $59.76 in afternoon trading. Novavax (NVAX) shares are down 14% to $42.60 after not being selected as a finalist.

ShowHide Related Items >><<
PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
PFE Pfizer
$35.72 /

-0.44 (-1.22%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRNA Moderna
$59.63 /

-0.25 (-0.42%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
NVAX Novavax
$48.10 /

-1.47 (-2.97%)

05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
05/12/20 B. Riley FBR
Novavax price target raised to $43 from $29 at B. Riley FBR
PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

Periodicals
Five coronavirus candidates selected by White House as finalists, NYT reports » 13:05
06/03/20
06/03
13:05
06/03/20
13:05
MRNA

Moderna

$59.64 /

-0.24 (-0.40%)

, AZN

AstraZeneca

$54.80 /

+0.08 (+0.15%)

, JNJ

Johnson & Johnson

$147.73 /

-0.43 (-0.29%)

, MRK

Merck

$81.94 /

+1.085 (+1.34%)

, PFE

Pfizer

$35.83 /

-0.335 (-0.93%)

Five companies have been…

Five companies have been selected by the Trump administration as the most likely to produce a vaccine for the coronavirus, The New York Times' Noah Weiland and David E. Sanger report, citing senior officials. The announcement of the decision will be made at the White House in the next few weeks, government officials say. The five companies are Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Merck (MRK) and Pfizer (PFE). Reference Link

ShowHide Related Items >><<
PFE Pfizer
$35.83 /

-0.335 (-0.93%)

MRNA Moderna
$59.64 /

-0.24 (-0.40%)

MRK Merck
$81.94 /

+1.085 (+1.34%)

JNJ Johnson & Johnson
$147.73 /

-0.43 (-0.29%)

AZN AstraZeneca
$54.80 /

+0.08 (+0.15%)

MRNA Moderna
$59.64 /

-0.24 (-0.40%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
AZN AstraZeneca
$54.80 /

+0.08 (+0.15%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
JNJ Johnson & Johnson
$147.73 /

-0.43 (-0.29%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$81.94 /

+1.085 (+1.34%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
PFE Pfizer
$35.83 /

-0.335 (-0.93%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
PFE Pfizer
$35.83 /

-0.335 (-0.93%)

MRNA Moderna
$59.64 /

-0.24 (-0.40%)

MRK Merck
$81.94 /

+1.085 (+1.34%)

JNJ Johnson & Johnson
$147.73 /

-0.43 (-0.29%)

AZN AstraZeneca
$54.80 /

+0.08 (+0.15%)

PFE Pfizer
$35.83 /

-0.335 (-0.93%)

MRNA Moderna
$59.64 /

-0.24 (-0.40%)

MRK Merck
$81.94 /

+1.085 (+1.34%)

JNJ Johnson & Johnson
$147.73 /

-0.43 (-0.29%)

AZN AstraZeneca
$54.80 /

+0.08 (+0.15%)

PFE Pfizer
$35.83 /

-0.335 (-0.93%)

MRNA Moderna
$59.64 /

-0.24 (-0.40%)

MRK Merck
$81.94 /

+1.085 (+1.34%)

JNJ Johnson & Johnson
$147.73 /

-0.43 (-0.29%)

AZN AstraZeneca
$54.80 /

+0.08 (+0.15%)

PFE Pfizer
$35.83 /

-0.335 (-0.93%)

MRNA Moderna
$59.64 /

-0.24 (-0.40%)

MRK Merck
$81.94 /

+1.085 (+1.34%)

JNJ Johnson & Johnson
$147.73 /

-0.43 (-0.29%)

AZN AstraZeneca
$54.80 /

+0.08 (+0.15%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.